Healthcare provider profile · identity verified

Sunita Ningthoujam, MD

Internal Medicine · BRONX, NY · NPI 1881907376

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	446	146
Amlodipine Besylate	Amlodipine Besylate	364	114
Rosuvastatin Calcium	Rosuvastatin Calcium	274	100
Levothyroxine Sodium	Levothyroxine Sodium	260	68
Losartan Potassium	Losartan Potassium	224	66
Gabapentin	Gabapentin	195	64
Lisinopril	Lisinopril	194	56
Albuterol Sulfate Hfa	Albuterol Sulfate	189	68
Metoprolol Succinate	Metoprolol Succinate	181	57
Metformin Hcl	Metformin Hcl	137	44
Omeprazole	Omeprazole	134	45
Simvastatin	Simvastatin	133	42
Hydrochlorothiazide	Hydrochlorothiazide	130	50
Jardiance	Empagliflozin	121	31
Escitalopram Oxalate	Escitalopram Oxalate	108	29
Fluticasone Propionate	Fluticasone Propionate	95	34
Alendronate Sodium	Alendronate Sodium	91	28
Ozempic	Semaglutide	90	15
Eliquis	Apixaban	85	19
Furosemide	Furosemide	84	26
Metformin Hcl Er	Metformin Hcl	78	25
Zolpidem Tartrate	Zolpidem Tartrate	77	18
Pantoprazole Sodium	Pantoprazole Sodium	70	17
Tamsulosin Hcl	Tamsulosin Hcl	69	18
Enalapril Maleate	Enalapril Maleate	65	23
Montelukast Sodium	Montelukast Sodium	59	17
Synthroid	Levothyroxine Sodium	57	16
Trulicity	Dulaglutide	57	suppressed
Famotidine	Famotidine	55	20
Ezetimibe	Ezetimibe	53	16
Atenolol	Atenolol	50	17
Nifedipine Er	Nifedipine	50	15
Duloxetine Hcl	Duloxetine Hcl	48	13
Finasteride	Finasteride	45	11
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	44	15
Trazodone Hcl	Trazodone Hcl	43	14
Allopurinol	Allopurinol	42	11
Sertraline Hcl	Sertraline Hcl	42	17
Glimepiride	Glimepiride	39	11
Clonazepam	Clonazepam	38	12
Mupirocin	Mupirocin	38	19
Doxycycline Hyclate	Doxycycline Hyclate	35	28
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	34	suppressed
Ammonium Lactate	Ammonium Lactate	33	17
Lorazepam	Lorazepam	33	11
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	33	32
Carvedilol	Carvedilol	32	11
Metoprolol Tartrate	Metoprolol Tartrate	32	11
Mirtazapine	Mirtazapine	32	suppressed
Potassium Chloride	Potassium Chloride	32	11
Pravastatin Sodium	Pravastatin Sodium	32	suppressed
Tramadol Hcl	Tramadol Hcl	32	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	31	11
Tizanidine Hcl	Tizanidine Hcl	31	suppressed
Breo Ellipta	Fluticasone/Vilanterol	30	suppressed
Januvia	Sitagliptin Phosphate	29	suppressed
Valacyclovir	Valacyclovir Hcl	28	12
Clopidogrel	Clopidogrel Bisulfate	26	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	26	11
Prednisone	Prednisone	26	21
Telmisartan	Telmisartan	26	suppressed
Xarelto	Rivaroxaban	25	suppressed
Diclofenac Sodium	Diclofenac Sodium	24	12
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	24	suppressed
Single Use Swab	Alcohol Antiseptic Pads	24	suppressed
Azelastine Hcl	Azelastine Hcl	23	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	22	11
Farxiga	Dapagliflozin Propanediol	22	suppressed
Ketoconazole	Ketoconazole	22	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	22	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	21	suppressed
Meloxicam	Meloxicam	21	suppressed
Azithromycin	Azithromycin	20	20
Ciprofloxacin Hcl	Ciprofloxacin Hcl	20	18
Spiriva Handihaler	Tiotropium Bromide	20	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	20	suppressed
Pregabalin	Pregabalin	19	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	19	suppressed
Alcohol Prep Pads	Alcohol Antiseptic Pads	18	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	18	suppressed
Paroxetine Hcl	Paroxetine Hcl	18	suppressed
Ventolin Hfa	Albuterol Sulfate	18	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	17	suppressed
Bupropion Xl	Bupropion Hcl	17	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	17	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	17	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	17	suppressed
Valsartan	Valsartan	17	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	16	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	16	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	16	suppressed
Amiodarone Hcl	Amiodarone Hcl	15	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	15	suppressed
Labetalol Hcl	Labetalol Hcl	15	suppressed
Meclizine Hcl	Meclizine Hcl	15	12
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	15	suppressed
Alprazolam	Alprazolam	14	suppressed
Glipizide	Glipizide	14	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	14	12
Baclofen	Baclofen	13	suppressed
Betamethasone Dipropionate	Betamethasone Dipropionate	13	suppressed
Colchicine	Colchicine	13	suppressed
Entresto	Sacubitril/Valsartan	13	suppressed
Estradiol	Estradiol	13	suppressed
Ibuprofen	Ibuprofen	13	suppressed
Lidocaine	Lidocaine	13	suppressed
Propranolol Hcl	Propranolol Hcl	13	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	13	suppressed
Fenofibrate	Fenofibrate,micronized	12	suppressed
Hydrocortisone	Hydrocortisone	12	suppressed
Lovastatin	Lovastatin	12	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	12	suppressed
Symbicort	Budesonide/Formoterol Fumarate	12	suppressed
Citalopram Hbr	Citalopram Hydrobromide	11	suppressed
Glipizide Er	Glipizide	11	suppressed
Hydralazine Hcl	Hydralazine Hcl	11	suppressed
Incruse Ellipta	Umeclidinium Bromide	11	suppressed
Mometasone Furoate	Mometasone Furoate	11	suppressed
Ranolazine Er	Ranolazine	11	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error